Literature DB >> 22508666

Site-specific cytomorphology of disseminated PC-3 prostate cancer cells visualized in vivo with fluorescent proteins.

Vladimir Bobek1, Robert M Hoffman, Katarina Kolostova.   

Abstract

Circulating tumor cells (CTC) may reach multiple organ sites. However, CTC seeding and growth in distant organs is not random. Each metastatic site may contain a specific subpopulation of the original metastatic tumor capable of growing at that site. The fluorescent orthotopic prostate cancer model (PC-3-GFP) model was used for immunomagnetic capture of CTC. The captured CTC were efficiently cultivated in vitro. PC-3-GFP cells were also isolated from various metastatic sites, grown in vitro and examined under fluorescence microscopy. The differential morphology was compared of primary tumor cells, CTC and disseminated (DTC) from multiple metastatic sites, from nude mice with orthotopic PC-3-GFP. The cultured captured CTC and DTC from various organs have distinctive morphologies. Distinct cancer cell morphologies were observed at different metastatic sites as well as among CTC. The distinct morphologies were maintained during in vitro culture. The results demonstrate extensive tumor heterogeneity that could account for the widely different behavior of cancer cells in a single tumor. Further hetereogeneity testing would be a big promise for personalizing the cancer treatment in the future.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22508666     DOI: 10.1002/dc.22843

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  5 in total

1.  Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.

Authors:  Jie-Fu Chen; Hao Ho; Jake Lichterman; Yi-Tsung Lu; Yang Zhang; Mitch A Garcia; Shang-Fu Chen; An-Jou Liang; Elisabeth Hodara; Haiyen E Zhau; Shuang Hou; Rafi S Ahmed; Daniel J Luthringer; Jiaoti Huang; Ker-Chau Li; Leland W K Chung; Zunfu Ke; Hsian-Rong Tseng; Edwin M Posadas
Journal:  Cancer       Date:  2015-05-14       Impact factor: 6.860

2.  Circulating giant macrophages as a potential biomarker of solid tumors.

Authors:  Daniel L Adams; Stuart S Martin; R Katherine Alpaugh; Monica Charpentier; Susan Tsai; Raymond C Bergan; Irene M Ogden; William Catalona; Saranya Chumsri; Cha-Mei Tang; Massimo Cristofanilli
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

3.  Development of an orthotopic model of human metastatic prostate cancer in the NOD-SCIDγ mouse (Mus musculus) anterior prostate.

Authors:  Federico F Cifuentes; Rodrigo H Valenzuela; Héctor R Contreras; Enrique A Castellón
Journal:  Oncol Lett       Date:  2015-07-22       Impact factor: 2.967

4.  Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.

Authors:  Tomohiro Fujiwara; Koji Uotani; Aki Yoshida; Takuya Morita; Yutaka Nezu; Eisuke Kobayashi; Akihiko Yoshida; Takenori Uehara; Toshinori Omori; Kazuhisa Sugiu; Tadashi Komatsubara; Ken Takeda; Toshiyuki Kunisada; Machiko Kawamura; Akira Kawai; Takahiro Ochiya; Toshifumi Ozaki
Journal:  Oncotarget       Date:  2017-05-16

5.  Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells.

Authors:  Lei Zhang; Chengyu Wu; Robert M Hoffman
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.